# W. P. Carey Inc.: financial statements, quarterly

WPC · NYSE · CIK 1025378 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wpc.md) · [Financials](/companies/wpc/financials.md) · [Filings](/companies/wpc/filings.md) · [Insiders](/companies/wpc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wpc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [449](/filings/0001025378-24-000142.md) | [412 d](/filings/0001025378-26-000036.md) | [390](/filings/0001025378-25-000064.md) | [390](/filings/0001025378-25-000130.md) | [397](/filings/0001025378-25-000144.md) | [406 d](/filings/0001025378-26-000036.md) | [410](/filings/0001025378-26-000078.md) | [431](/filings/0001025378-26-000119.md) | [431](/filings/0001025378-25-000144.md) | [445 d](/filings/0001025378-26-000036.md) | [455](/filings/0001025378-26-000078.md) | [461](/filings/0001025378-26-000119.md) |
| Cost of revenue | $m | [0.1](/filings/0001628280-23-036734.md) | [0.0 d](/filings/0001025378-24-000037.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [77.0](/filings/0001628280-23-036734.md) | [72.2 d](/filings/0001025378-24-000037.md) | [68.7](/filings/0001025378-24-000081.md) | [65.3](/filings/0001025378-25-000130.md) | [72.5](/filings/0001025378-25-000144.md) | [70.9 d](/filings/0001025378-26-000036.md) | [68.8](/filings/0001025378-26-000078.md) | [71.8](/filings/0001025378-26-000119.md) | [75.2](/filings/0001025378-25-000144.md) | [75.4 d](/filings/0001025378-26-000036.md) | [78.5](/filings/0001025378-26-000078.md) | [79.0](/filings/0001025378-26-000119.md) |
| Income tax | $m | [5.1](/filings/0001025378-24-000142.md) | [13.7 d](/filings/0001025378-26-000036.md) | [8.7](/filings/0001025378-25-000064.md) | [6.2](/filings/0001025378-25-000130.md) | [9.0](/filings/0001025378-25-000144.md) | [7.8 d](/filings/0001025378-26-000036.md) | [11.6](/filings/0001025378-26-000078.md) | [13.1](/filings/0001025378-26-000119.md) | [8.5](/filings/0001025378-25-000144.md) | [(1.3) d](/filings/0001025378-26-000036.md) | [14.6](/filings/0001025378-26-000078.md) | [13.1](/filings/0001025378-26-000119.md) |
| Net income | $m | [125](/filings/0001025378-24-000142.md) | [144 d](/filings/0001025378-26-000036.md) | [159](/filings/0001025378-25-000064.md) | [143](/filings/0001025378-25-000130.md) | [112](/filings/0001025378-25-000144.md) | [47.0 d](/filings/0001025378-26-000036.md) | [126](/filings/0001025378-26-000078.md) | [51.2](/filings/0001025378-26-000119.md) | [141](/filings/0001025378-25-000144.md) | [148 d](/filings/0001025378-26-000036.md) | [176](/filings/0001025378-26-000078.md) | [185](/filings/0001025378-26-000119.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: not reported

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001628280-23-036734.md) | [0.6](/filings/0001025378-26-000036.md) | [0.8](/filings/0001025378-24-000081.md) | [1.1](/filings/0001025378-24-000119.md) | [0.8](/filings/0001025378-24-000142.md) | [0.6](/filings/0001025378-26-000036.md) | [0.2](/filings/0001025378-25-000064.md) | [0.2](/filings/0001025378-25-000130.md) | [0.2](/filings/0001025378-25-000144.md) | [0.2](/filings/0001025378-26-000119.md) | [0.2](/filings/0001025378-26-000078.md) | [0.2](/filings/0001025378-26-000119.md) |
| Total assets | $bn | [18.6](/filings/0001628280-23-036734.md) | [18.0](/filings/0001025378-25-000031.md) | [17.6](/filings/0001025378-24-000081.md) | [17.8](/filings/0001025378-24-000119.md) | [17.6](/filings/0001025378-24-000142.md) | [17.5](/filings/0001025378-26-000036.md) | [17.3](/filings/0001025378-25-000064.md) | [18.0](/filings/0001025378-25-000130.md) | [18.0](/filings/0001025378-25-000144.md) | [18.0](/filings/0001025378-26-000119.md) | [18.2](/filings/0001025378-26-000078.md) | [18.6](/filings/0001025378-26-000119.md) |
| Total liabilities | $bn | [9.5](/filings/0001628280-23-036734.md) | [9.3](/filings/0001025378-25-000031.md) | [8.9](/filings/0001025378-24-000081.md) | [9.1](/filings/0001025378-24-000119.md) | [9.0](/filings/0001025378-24-000142.md) | [9.1](/filings/0001025378-26-000036.md) | [8.9](/filings/0001025378-25-000064.md) | [9.8](/filings/0001025378-25-000130.md) | [9.8](/filings/0001025378-25-000144.md) | [9.9](/filings/0001025378-26-000119.md) | [9.8](/filings/0001025378-26-000078.md) | [9.9](/filings/0001025378-26-000119.md) |
| Long-term debt | $bn | [8.3](/filings/0001628280-23-036734.md) | [8.1](/filings/0001025378-25-000031.md) | [7.9](/filings/0001025378-24-000081.md) | [8.1](/filings/0001025378-24-000119.md) | [8.0](/filings/0001025378-24-000142.md) | [8.0](/filings/0001025378-26-000036.md) | [7.9](/filings/0001025378-25-000064.md) | [8.6](/filings/0001025378-25-000130.md) | [8.7](/filings/0001025378-25-000144.md) | [8.7](/filings/0001025378-26-000119.md) | [8.8](/filings/0001025378-26-000078.md) | [8.9](/filings/0001025378-26-000119.md) |
| Shareholders' equity | $bn | [9.1](/filings/0001628280-23-036734.md) | [8.7](/filings/0001025378-25-000031.md) | [8.7](/filings/0001025378-24-000081.md) | [8.6](/filings/0001025378-24-000119.md) | [8.6](/filings/0001025378-24-000142.md) | [8.4](/filings/0001025378-26-000036.md) | [8.4](/filings/0001025378-25-000064.md) | [8.2](/filings/0001025378-25-000130.md) | [8.2](/filings/0001025378-25-000144.md) | [8.1](/filings/0001025378-26-000119.md) | [8.3](/filings/0001025378-26-000078.md) | [8.7](/filings/0001025378-26-000119.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [282 d](/filings/0001025378-24-000142.md) | [261 d](/filings/0001025378-26-000036.md) | [1,036](/filings/0001025378-25-000064.md) | [221 d](/filings/0001025378-25-000130.md) | [280 d](/filings/0001025378-25-000144.md) | [296 d](/filings/0001025378-26-000036.md) | [273](/filings/0001025378-26-000078.md) | [404 d](/filings/0001025378-26-000119.md) | [300 d](/filings/0001025378-25-000144.md) | [305 d](/filings/0001025378-26-000036.md) | [283](/filings/0001025378-26-000078.md) | [333 d](/filings/0001025378-26-000119.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [230 d](/filings/0001025378-24-000142.md) | [230 d](/filings/0001025378-26-000036.md) | [190](/filings/0001025378-25-000064.md) | [190 d](/filings/0001025378-25-000130.md) | [192 d](/filings/0001025378-25-000144.md) | [193 d](/filings/0001025378-26-000036.md) | [195](/filings/0001025378-26-000078.md) | [196 d](/filings/0001025378-26-000119.md) | [198 d](/filings/0001025378-25-000144.md) | [201 d](/filings/0001025378-26-000036.md) | [205](/filings/0001025378-26-000078.md) | [209 d](/filings/0001025378-26-000119.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [204](/filings/0001628280-23-036734.md) | [212](/filings/0001025378-24-000081.md) | [215](/filings/0001025378-24-000119.md) | [215](/filings/0001025378-24-000142.md) | [220](/filings/0001025378-25-000064.md) | [220](/filings/0001025378-25-000130.md) | [220](/filings/0001025378-25-000144.md) | [221](/filings/0001025378-26-000078.md) | [221](/filings/0001025378-26-000119.md) | [221](/filings/0001025378-25-000144.md) | [222](/filings/0001025378-26-000078.md) | [227](/filings/0001025378-26-000119.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 227,816,879 at 2026-07-24, from the cover of the [10-Q filed 2026-07-29](/filings/0001025378-26-000119.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.